Analysis of transmitted drug resistance in Spain in the years 2007–2010 documents a decline in mutations to the non-nucleoside drug class S. Monge, V.

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Figure 1 Inclusion criteria, exclusion criteria, and criteria for virologic failure. CDC, Centers for Disease Control and Prevention; ddC, zalcitabine;

L.H. Su, T.L. Wu, C.H. Chiu Clinical Microbiology and Infection

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Clinical and virologic follow-up in perinatally HIV-1-infected children and adolescents in Madrid with triple-class antiretroviral drug-resistant viruses

Protease inhibitor monotherapy is effective in controlling human immunodeficiency virus 1 shedding in the male genital tract A. Torres-Cornejo, O.J.

Prevalence of drug resistance and newly recognised treatment-related substitutions in the HIV-1 reverse transcriptase and protease genes from HIV-positive.

L. Boyanova Clinical Microbiology and Infection

High prevalence of azithromycin resistance to Treponema pallidum in geographically different areas in China X.-S. Chen, Y.-P. Yin, W.-H. Wei, H.-C. Wang,

M. Colafigli, C. Torti, E. M. Trecarichi, L. Albini, A. Rosi, V

Gut bacterial microbiota and obesity

L.H. Su, T.L. Wu, C.H. Chiu Clinical Microbiology and Infection

I.J. Schalk Clinical Microbiology and Infection

Salvage therapy for multidrug-resistant tuberculosis

D. Khalil, M. Hultin, M.U. Rashid, B. Lund

Herpes zoster in non-hospitalized children

Clinical characteristics of Haemophilus influenzae meningitis in Denmark in the post- vaccination era T.I. Pedersen, M. Howitz, C. Østergaard Clinical.

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

Hepatitis B and C virus-related carcinogenesis

A. F. Simonetti, C. Garcia-Vidal, D. Viasus, D. García-Somoza, J

Antimicrobial drug use and infection control practices associated with the prevalence of methicillin-resistant Staphylococcus aureus in European hospitals

Clinical impact and prevalence of MRSA CC398 and differences between MRSA-TetR and MRSA-TetS in an area of Spain with a high density of pig farming: a.

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia D. Kese, M. Maticic, M. Potocnik Clinical.

Prevalence of Toscana virus antibodies in residents of Croatia

Drug-resistant human immunodefiency virus

H. Adibhesami, M. Douraghi, M. Rahbar, A. Abdollahi

Analysis of intracellular human immunodeficiency virus (HIV)-1 drug resistance mutations in multi-failed HIV-1-infected patients treated with a salvage.

Vector control: a cornerstone in the malaria elimination campaign

Antiretroviral therapy for initial human immunodeficiency virus/AIDS treatment: critical appraisal of the evidence from over 100 randomized trials and.

Training for the infectious diseases speciality in Norway

Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals C. Nonhoff, O. Denis,

Z. Wang, Z. Cui, Y. Li, T. Hou, X. Liu, Y. Xi, Y. Liu, H. Li, Q. He

Effects of gentamicin monotherapy for the initial treatment of community-onset complicated non-obstructive acute pyelonephritis due to Enterobacteriaceae.

Salvage therapy for multidrug-resistant tuberculosis

V Duque, ÁA. Holguín, M. Silvestre, J. GonzÁAlez-Lahoz, V. Soriano

G. Rocheleau, C.J. Brumme, J. Shoveller, V.D. Lima, P.R. Harrigan

Decreasing rates of resistance to penicillin, but not erythromycin, in Streptococcus pneumoniae after introduction of a policy to restrict antibiotic.

Levofloxacin in the treatment of ventilator-associated pneumonia

G. Pappas Clinical Microbiology and Infection

Metagenomics and probiotics

Update on emergence of HIV-1 resistance to antiretroviral drug classes in an Italian national database: 2007–2009 S. Di Giambenedetto, M. Prosperi, I.

Hepatitis B and C virus-related carcinogenesis

T.M. File Clinical Microbiology and Infection

Systematic review of antibiotic consumption in acute care hospitals

Antibacterial drug discovery in the 21st century

The role of antimalarial treatment in the elimination of malaria

Abstracts cont. Clinical Microbiology and Infection

J. R. Blanco, C. Gutierrez, M. Zabalza, J. Salcedo, I. Erdozain, J. A

Antimicrobial drug development – the past, the present, and the future

Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,

S. M. Bartsch, J. A. McKinnell, L. E. Mueller, L. G. Miller, S. K

Clinical Microbiology and Infection

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

Z. Erjavec, H. Kluin-Nelemans, P.E. Verweij

Panton–Valentine leukocidin-encoding bacteriophage and gene sequence variation in community-associated methicillin-resistant Staphylococcus aureus J.A.

The atypical pneumonias: clinical diagnosis and importance

Modelling during an emergency: the 2009 H1N1 influenza pandemic

Are we losing the fight against malaria one more time?

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

New patterns of HIV-1 resistance during HAART

J.A. Pérez-Molina, F. Fernández Clinical Microbiology and Infection

Human immunodeficiency virus-1 B and non-B subtypes with the same drug resistance pattern respond similarly to antiretroviral therapy M. Franzetti, M.

Impact of antibiotic restrictions: the patient's perspective

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Analysis of transmitted drug resistance in Spain in the years 2007–2010 documents a decline in mutations to the non-nucleoside drug class S. Monge, V. Guillot, M. Alvarez, A. Peña, P. Viciana, S. García-Bujalance, M.J. Pérez Elias, J.A. Iribarren, F. Gutiérrez, M. Itziar Casado Clinical Microbiology and Infection Volume 18, Issue 11, Pages E485-E490 (November 2012) DOI: 10.1111/1469-0691.12011 Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Prevalence of TDR by antiretroviral family and non-B subtypes between 2007 and 2010. NRTI, nucleoside reverse transcriptase inhibitors; NNRTI, non-nucleoside reverse transcriptase inhibitors; PI, protease inhibitors. CRFs, circulating recombinant forms. A significant decreasing trend was found for resistance to NNRTIs (p for trend = 0.044). Clinical Microbiology and Infection 2012 18, E485-E490DOI: (10.1111/1469-0691.12011) Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions